Medical Societies Endorse Respiratory Vaccine Guidance

A multi-society panel backed vaccine recommendations for influenza, RSV, and COVID-19 aligned with ACIP guidance issued before June 2025.

Updated on Nov. 5, 2026 in Asthma

Medical Societies Endorse Respiratory Vaccine Guidance

Live Poll

Do you trust your doctor's vaccine advice more than federal health agency guidance?

A Vaccine Guidance Review Panel endorsed recommendations for influenza, RSV, and COVID-19 vaccines for adults and children. The American Thoracic Society, AAAAI, CHEST, and SCCM unanimously endorsed guidance from AAP, AAFP, ACOG, and IDSA.

Why it matters

The panel was formed to protect respiratory health after 2025 changes to CDC and ACIP processes that could lead to harmful updates to the vaccine schedule. Clinicians are seeking guidance for high-risk patients ahead of the upcoming respiratory virus season.

The endorsed recommendations are aligned with ACIP guidance issued before June 2025, the reference point used by the four endorsing societies. The specific schedule changes deemed potentially harmful were not detailed in the source material.

The players

American Thoracic Society

A professional medical society focused on pulmonary, critical care, and sleep medicine that reviewed the vaccine guidance.

American Academy of Pediatrics

A national organization of pediatricians whose vaccine guidance was reviewed and endorsed by the panel.

Advisory Committee on Immunization Practices

A federal advisory body that issues vaccine recommendations and whose pre-June 2025 guidance the endorsed recommendations align with.

The details

The four societies reviewed the vaccination-development process and resulting guidance from AAP, AAFP, ACOG, and IDSA before reaching consensus. The endorsement covers influenza, RSV, and COVID-19 vaccines for both adults and children.

- June 2025: Cutoff date for ACIP recommendations used as the alignment reference.
- 2025: CDC and ACIP process changes created potential harmful schedule updates.
- Upcoming respiratory virus season: Clinicians need guidance for high-risk patients.

Big Picture

The endorsement reaffirms ACIP recommendations issued before June 2025 as the reference standard, following 2025 changes to CDC and ACIP processes that prompted concern over the vaccine schedule. Medical societies are now providing parallel guidance to fill the gap.

Patients at high risk for respiratory illness may need to review their influenza, RSV, and COVID-19 vaccination plans with a clinician before the upcoming respiratory virus season. Parents should check whether their children's vaccines match the endorsed pediatric recommendations.

The takeaway

Staying current with vaccine recommendations from both federal agencies and major medical societies helps patients and families make informed decisions during respiratory virus season. Consulting a clinician about individual risk is the most reliable next step.